Radiolabeling, quality control, biodistribution, and imaging studies of 177 Lu-ibandronate-Reference-Cited by-同舟云学术

Radiolabeling, quality control, biodistribution, and imaging studies of 177 Lu-ibandronate

Published:2018-11-28 Issue:1 Volume:62 Page:43-51
ISSN:0362-4803
Container-title:Journal of Labelled Compounds and Radiopharmaceuticals
language:en
Short-container-title:J Label Compd Radiopharm

Author:

Xu Qin¹²^ORCID,Zhang Shumao¹²,Zhao Yan¹²,Feng Yue¹²,Liu Lin¹²,Cai Liang¹³,Zhang Wei¹²,Huang Zhanwen¹²,Wei Hongyuan⁴⁵^ORCID,Zhuo Liangang⁴⁵,Chen Yue¹²

Affiliation:

1. Department of Nuclear Medicine; Affiliated Hospital of Southwest Medical University; Luzhou China

2. Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province; Luzhou China

3. State Key laboratory of Quality Research in Chinese Medicine/Macau Institute for Applied Research in Medicine and Health; Macau University of Science and Technology; Taipa Macau SAR PR China

4. Isotope Technology and Application Laboratory; Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics; Mianyang PR China

5. Key Laboratory of Nuclear Medicine and Molecular Imaging of Sichuan Province; Mianyang China

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jlcr.3694/fullpdf

Reference19 articles.

1. Skeletal metastases;Galasko;Clin Orthop Relat Res,1986

2. Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot study;Mancini;J Clin Oncol off J Am Soc Clin Oncol,2004

3. Ibandronate in metastatic bone pain;Heidenreich;Semin Oncol,2004

4. Targeted radio-nuclide therapy of skeletal metastases;Sartor;Cancer Treat Rev,2013

5. Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent;Mathe;Nucl Med Biol,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of 188Re- IBA as a novel radiopharmaceutical for bone marrow ablation;Applied Radiation and Isotopes;2024-06

2. Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy;Journal of Medicinal Chemistry;2023-09-05

3. Biodistribution and Internal Dosimetry of 68Ga-DOTA-IBA PET Imaging for Patients With Bone Metastases;Clinical Nuclear Medicine;2023-07-05

4. Lutetium177-Labeled DOTA-Ibandronate: A Novel Radiopharmaceutical for Targeted Treatment of Bone Metastases;Molecular Pharmaceutics;2023-02-20

5. Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA;Frontiers in Oncology;2022-12-14